LUNG CANCER
October 18, 2023
Review of Selected NMEs 2023
Spotlighting newly approved medications that treat anemia due to chronic kidney disease, breast cancer, leukemia, and lung cancer.July 18, 2023
A Look at NSCLC and Its Current and Emerging Therapies
March 3, 2023
Targeted Therapies Underused in Medicaid Programs
March 3, 2023
Cost Effectiveness of Risk-Based Lung Cancer Screening
February 15, 2023
Impact of NSAIDs on Immunotherapy Efficacy in NSCLC
February 15, 2023
Artificial Intelligence Tool Predicts Risk of Lung Cancer
February 15, 2023
Updated Exploratory Analysis From Trial With NSCLC Patients
November 3, 2022
Lung Cancer Epidemiology
Copyright © 2000 - 2023 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.